InvestorsHub Logo
Followers 43
Posts 5751
Boards Moderated 0
Alias Born 04/12/2021

Re: None

Saturday, 09/17/2022 1:22:04 PM

Saturday, September 17, 2022 1:22:04 PM

Post# of 334
Patent doesn’t fix this imo:

“4:21p ET 8/11/2022 - Benzinga
BioTelemetry Q2 EPS $(0.43) Misses $(0.27) Estimate

BioTelemetry (NASDAQ:BEAT) reported quarterly losses of $(0.43) per share which missed the analyst consensus estimate of $(0.27) by 59.26 percent.

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.”

my posts are always theory and not financial advice

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent BEAT News